Data Presentation
Janssen to Present Data in Treatment-Resistant Mental Ilnesses
Janssen Pharmaceutical Companies
PR-M05-18-NI-029May 08, 2018
Clinical Trials
Alkermes Completes Patient Enrollment in Pivotal Weight Study of ALKS 3831 for Schizophrenia
Alkermes
PR-M05-18-NI-007May 02, 2018